title: Letter to the editor regarding the use of intravenous immunoglobulin (IVIG) in asthma.
authors.forename: W T
authors.initials: WT
authors.lastname: Shearer
authors.forename: S L
authors.initials: SL
authors.lastname: Abramson
authors.forename: D C
authors.initials: DC
authors.lastname: Adelman
authors.forename: B
authors.initials: B
authors.lastname: Corn
authors.forename: C
authors.initials: C
authors.lastname: Cunningham-Rundles
authors.forename: J L
authors.initials: JL
authors.lastname: Kishiyama
authors.forename: W
authors.initials: W
authors.lastname: Richmond
authors.forename: R S
authors.initials: RS
authors.lastname: Shames
authors.forename: K
authors.initials: K
authors.lastname: Sperber
authors.forename: E R
authors.initials: ER
authors.lastname: Stiehm
authors.forename: D J
authors.initials: DJ
authors.lastname: Valacer
mesh_terms: D001249:Asthma / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*
chemical_list: D016756:Immunoglobulins, Intravenous